Open-mkt buys · 90d
$22.02M
11 trades · 7 insiders
Open-mkt sales · 90d
$13.31M
35 trades · 3 insiders
Net · 90d
$8.72M
Insiders on file
18
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| HEALY JAMES | Director | 25 | $30.94M | $0 | 2026-10-28 |
| Sanchez Ramiro | Director | 4 | $98.5K | $0 | 2026-10-23 |
| Young Wendy B. | Director | 6 | $240.4K | $0 | 2026-10-22 |
| Silva Paul M | Director | 4 | $99.6K | $0 | 2026-10-22 |
| PAUL STEVEN M | Director | 5 | $2.00M | $0 | 2026-10-22 |
| MARAGANORE JOHN | Director | 4 | $248.9K | $0 | 2026-10-22 |
| Ceesay Abraham | Chief Executive Officer, Director | 60 | $0 | $12.21M | 2026-10-21 |
| Ignelzi Troy A. | Chief Financial Officer | 6 | $244.5K | $0 | 2026-10-21 |
| Gault Cheryl | Chief Operations Officer | 19 | $0 | $1.43M | 2026-09-30 |
| Yeleswaram Krishnaswamy | Chief Development Officer | 19 | $0 | $7.01M | 2026-08-25 |
| Huber Reid M | Director | 3 | $499.4K | $0 | 2026-06-10 |
| PEREZ ROBERT J | Director | 3 | $0 | $0 | 2026-06-10 |
| Third Rock Ventures V, L.P. | 10% Owner | 7 | $0 | $6.12M | 2026-05-26 |
| Third Rock Ventures VI, L.P. | 10% Owner | 3 | $0 | $28.27M | 2026-05-08 |
| Bredt David | Chief Scientific Officer | 27 | $0 | $2.16M | 2026-02-19 |
| Sevigny Jeffrey | Chief Medical Officer | 2 | $0 | $0 | 2026-02-02 |
| NELSEN ROBERT | 10% Owner | 3 | $0 | $0 | 2024-06-10 |
| Galer Bradley S. | Chief Medical Officer | 1 | $0 | $0 | 2024-06-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| HEALY JAMES | Director | P Buy | 2026-10-28 | 2026-10-30 | 6,933 | $21.00 | $145.6K | 25,267 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2026-10-28 | 2026-10-30 | 3,772 | $21.00 | $79.2K | 14,924 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2026-10-28 | 2026-10-30 | 6,395 | $21.00 | $134.3K | 17,990 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2026-10-28 | 2026-10-30 | 952,380 | $21.00 | $20.00M | 2,815,707 | SEC↗ |
| Sanchez Ramiro | Director | P Buy | 2026-10-23 | 2026-10-23 | 3,600 | $27.35 | $98.5K | 3,600 | SEC↗ |
| Silva Paul M | Director | P Buy | 2026-10-22 | 2026-10-22 | 3,680 | $27.07 | $99.6K | 3,680 | SEC↗ |
| Young Wendy B. | Director | P Buy | 2026-10-22 | 2026-10-22 | 3,789 | $26.39 | $100.0K | 13,289 | SEC↗ |
| PAUL STEVEN M | Director | P Buy | 2026-10-22 | 2026-10-22 | 35,714 | $27.28 | $974.3K | 77,380 | SEC↗ |
| MARAGANORE JOHN | Director | P Buy | 2026-10-22 | 2026-10-22 | 1,172 | $26.92 | $31.5K | 9,411 | SEC↗ |
| MARAGANORE JOHN | Director | P Buy | 2026-10-22 | 2026-10-22 | 8,239 | $26.38 | $217.3K | 8,239 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | P Buy | 2026-10-21 | 2026-10-21 | 5,500 | $26.10 | $143.6K | 15,500 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-10-21 | 2026-10-23 | 2,210 | $29.16 | $64.4K | 450,035 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-10-07 | 2026-10-08 | 1,147 | $30.66 | $35.2K | 452,245 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-10-06 | 2026-10-08 | 3,375 | $32.03 | $108.1K | 453,392 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-09-30 | 2026-10-01 | 2,075 | $33.76 | $70.0K | 139,914 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-09-30 | 2026-10-01 | 7,925 | $33.04 | $261.8K | 141,989 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-09-23 | 2026-09-24 | 215 | $39.86 | $8.6K | 456,810 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-09-23 | 2026-09-24 | 1,952 | $39.05 | $76.2K | 457,025 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-09-23 | 2026-09-24 | 43 | $41.05 | $1.8K | 456,767 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-09-23 | 2026-09-24 | 43 | $41.05 | $1.8K | 456,767 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-09-23 | 2026-09-24 | 215 | $39.86 | $8.6K | 456,810 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-09-23 | 2026-09-24 | 1,952 | $39.05 | $76.2K | 457,025 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-09-08 | 2026-09-09 | 1,069 | $46.01 | $49.2K | 458,977 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-09-08 | 2026-09-09 | 7,141 | $45.56 | $325.3K | 460,046 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-09-08 | 2026-09-09 | 1,069 | $46.01 | $49.2K | 458,977 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-09-08 | 2026-09-09 | 7,141 | $45.55 | $325.3K | 460,046 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-25 | 2026-08-26 | 20,799 | $50.31 | $1.05M | 212,063 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-25 | 2026-08-26 | 16,201 | $51.06 | $827.2K | 195,862 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-25 | 2026-08-26 | 18,921 | $49.57 | $937.9K | 467,187 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-25 | 2026-08-26 | 16,201 | $51.06 | $827.2K | 195,862 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-25 | 2026-08-26 | 20,799 | $50.31 | $1.05M | 212,063 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-25 | 2026-08-26 | 18,921 | $49.57 | $938.0K | 467,187 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-24 | 2026-08-26 | 13,160 | $50.00 | $658.0K | 232,862 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-24 | 2026-08-26 | 13,160 | $50.00 | $658.0K | 232,862 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-19 | 2026-08-20 | 404 | $49.90 | $20.2K | 246,022 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-08-19 | 2026-08-20 | 404 | $49.90 | $20.2K | 246,022 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-11 | 2026-08-12 | 5,794 | $48.62 | $281.7K | 486,108 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-11 | 2026-08-12 | 19,500 | $48.04 | $936.8K | 491,902 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-11 | 2026-08-12 | 3,664 | $46.90 | $171.8K | 511,402 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-11 | 2026-08-12 | 5,794 | $48.62 | $281.7K | 486,108 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-11 | 2026-08-12 | 19,500 | $48.04 | $936.8K | 491,902 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-11 | 2026-08-12 | 3,664 | $46.90 | $171.8K | 511,402 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-10 | 2026-08-12 | 8,370 | $46.75 | $391.3K | 515,066 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-08-10 | 2026-08-12 | 14,171 | $45.97 | $651.4K | 523,436 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-10 | 2026-08-12 | 8,370 | $46.75 | $391.3K | 515,066 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-08-10 | 2026-08-12 | 14,171 | $45.97 | $651.5K | 523,436 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-07-27 | 2026-07-29 | 7 | $42.74 | $299 | 537,607 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-07-27 | 2026-07-29 | 2,203 | $42.11 | $92.8K | 537,614 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-07-27 | 2026-07-29 | 7 | $42.73 | $299 | 537,607 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer, Dir | S Sale | 2026-07-27 | 2026-07-29 | 2,203 | $42.11 | $92.8K | 537,614 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-07-14 | 2026-07-15 | 5,481 | $39.72 | $217.7K | 542,546 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-07-14 | 2026-07-15 | 2,729 | $40.57 | $110.7K | 539,817 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-06-30 | 2026-07-01 | 3,792 | $41.39 | $157.0K | 154,222 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-06-30 | 2026-07-01 | 1,900 | $40.09 | $76.2K | 158,014 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-06-30 | 2026-07-01 | 3,308 | $42.17 | $139.5K | 150,914 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-06-30 | 2026-07-01 | 1,000 | $43.15 | $43.1K | 149,914 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-06-29 | 2026-07-01 | 7,344 | $39.77 | $292.1K | 548,903 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-06-29 | 2026-07-01 | 876 | $40.34 | $35.3K | 548,027 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Young Wendy B. | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| HEALY JAMES | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Silva Paul M | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| PAUL STEVEN M | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| PEREZ ROBERT J | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| MARAGANORE JOHN | Director | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | S Sale | 2026-05-26 | 2026-05-28 | 18,572 | $40.05 | $743.8K | 6,280,525 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | S Sale | 2026-05-11 | 2026-05-13 | 133,618 | $40.24 | $5.38M | 6,299,097 | SEC↗ |
| Third Rock Ventures VI, L.P. | 10% Owner | S Sale | 2026-05-08 | 2026-05-11 | 5,018 | $40.31 | $202.3K | 6,432,715 | SEC↗ |
| Third Rock Ventures VI, L.P. | 10% Owner | S Sale | 2026-05-07 | 2026-05-11 | 271,495 | $40.12 | $10.89M | 6,437,733 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-04-17 | 2026-04-21 | 20,225 | $39.99 | $808.8K | 246,426 | SEC↗ |
| Third Rock Ventures VI, L.P. | 10% Owner | S Sale | 2026-04-17 | 2026-04-21 | 426,005 | $40.32 | $17.18M | 6,709,228 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-04-14 | 2026-04-14 | 10,200 | $35.08 | $357.8K | 266,651 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-04-13 | 2026-04-14 | 9,165 | $34.97 | $320.5K | 276,851 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-04-10 | 2026-04-14 | 500 | $34.98 | $17.5K | 286,016 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-04-08 | 2026-04-09 | 360 | $34.90 | $12.6K | 286,516 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-03-30 | 2026-03-31 | 2,839 | $28.55 | $81.1K | 159,914 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-03-30 | 2026-03-31 | 7,161 | $28.04 | $200.8K | 162,753 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2026-03-25 | 2026-03-26 | 10,115 | $29.99 | $303.3K | 286,876 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2026-03-05 | 2026-03-09 | 2,014 | $28.93 | $58.3K | 169,914 | SEC↗ |
| Bredt David | Chief Scientific Officer | M Exercise deriv | 2026-02-19 | 2026-02-19 | 6,000 | — | $0 | 88,080 | SEC↗ |
| Bredt David | Chief Scientific Officer | M Exercise | 2026-02-19 | 2026-02-19 | 6,000 | $1.80 | $10.8K | 393,075 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-02-18 | 2026-02-19 | 2,281 | $29.80 | $68.0K | 556,247 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-02-18 | 2026-02-19 | 2,983 | $29.04 | $86.6K | 22,829 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-02-18 | 2026-02-19 | 2,100 | $29.80 | $62.6K | 20,729 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-02-18 | 2026-02-19 | 3,552 | $29.05 | $103.2K | 558,528 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2026-02-17 | 2026-02-19 | 900 | $28.02 | $25.2K | 394,675 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2026-02-17 | 2026-02-19 | 5,400 | $28.95 | $156.3K | 389,275 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2026-02-17 | 2026-02-19 | 2,200 | $29.59 | $65.1K | 387,075 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 132,000 | — | $0 | 132,000 | SEC↗ |
| Bredt David | Chief Scientific Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 103,000 | — | $0 | 103,000 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 148,000 | — | $0 | 148,000 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 428,000 | — | $0 | 428,000 | SEC↗ |
| Sevigny Jeffrey | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-01-20 | 2026-01-22 | 5,833 | $26.12 | $152.4K | 562,080 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2026-01-20 | 2026-01-22 | 5,083 | $26.11 | $132.7K | 25,812 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2026-01-15 | 2026-01-16 | 200 | $27.40 | $5.5K | 395,575 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2026-01-15 | 2026-01-16 | 8,300 | $26.83 | $222.7K | 395,775 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | S Sale | 2025-12-31 | 2026-01-05 | 2,840 | $30.05 | $85.3K | 296,991 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | A Award | 2025-12-31 | 2026-01-05 | 9,000 | — | $0 | 299,831 | SEC↗ |
| Bredt David | Chief Scientific Officer | A Award | 2025-12-31 | 2026-01-05 | 18,000 | — | $0 | 410,642 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-12-31 | 2026-01-05 | 6,567 | $30.05 | $197.3K | 404,075 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 2,147 | $28.84 | $61.9K | 33,831 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 600 | $31.04 | $18.6K | 567,913 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 2,441 | $28.84 | $70.4K | 571,305 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 2,421 | $30.04 | $72.7K | 31,410 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 515 | $31.04 | $16.0K | 30,895 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-12-17 | 2025-12-18 | 2,792 | $30.04 | $83.9K | 568,513 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-12-15 | 2025-12-16 | 796 | $30.68 | $24.4K | 392,642 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-12-15 | 2025-12-16 | 7,704 | $29.95 | $230.7K | 393,438 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | M Exercise deriv | 2025-11-26 | 2025-12-01 | 5,000 | — | $0 | 105,407 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2025-11-26 | 2025-12-01 | 5,000 | $30.10 | $150.5K | 171,928 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | M Exercise | 2025-11-26 | 2025-12-01 | 5,000 | $1.80 | $9.0K | 176,928 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-11-17 | 2025-11-18 | 3,156 | $24.84 | $78.4K | 406,486 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-11-17 | 2025-11-18 | 5,344 | $25.39 | $135.7K | 401,142 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-11-17 | 2025-11-18 | 2,841 | $25.44 | $72.3K | 35,978 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-11-17 | 2025-11-18 | 2,777 | $24.92 | $69.2K | 576,802 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-11-17 | 2025-11-18 | 3,056 | $25.43 | $77.7K | 573,746 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-11-17 | 2025-11-18 | 2,242 | $24.91 | $55.8K | 38,819 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-10-15 | 2025-10-16 | 755 | $26.17 | $19.8K | 41,061 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-10-15 | 2025-10-16 | 4,328 | $25.75 | $111.4K | 41,816 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-10-15 | 2025-10-16 | 4,647 | $25.72 | $119.5K | 580,765 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-10-15 | 2025-10-16 | 1,186 | $26.14 | $31.0K | 579,579 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-10-15 | 2025-10-16 | 7,418 | $25.73 | $190.9K | 410,724 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-10-15 | 2025-10-16 | 1,082 | $26.16 | $28.3K | 409,642 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-09-17 | 2025-09-19 | 700 | $27.04 | $18.9K | 46,144 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-09-17 | 2025-09-19 | 34,885 | $26.30 | $917.5K | 46,844 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-09-17 | 2025-09-19 | 1,400 | $26.87 | $37.6K | 585,412 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | S Sale | 2025-09-17 | 2025-09-19 | 39,435 | $26.30 | $1.04M | 586,812 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-09-15 | 2025-09-17 | 3,402 | $24.66 | $83.9K | 418,142 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-09-15 | 2025-09-17 | 5,098 | $23.88 | $121.7K | 421,544 | SEC↗ |
| PAUL STEVEN M | Director | P Buy | 2025-09-12 | 2025-09-15 | 13,382 | $24.97 | $334.1K | 41,666 | SEC↗ |
| PAUL STEVEN M | Director | P Buy | 2025-09-12 | 2025-09-15 | 28,284 | $24.50 | $693.0K | 28,284 | SEC↗ |
| Huber Reid M | Director | P Buy | 2025-09-12 | 2025-09-15 | 20,400 | $24.48 | $499.4K | 20,400 | SEC↗ |
| Young Wendy B. | Director | P Buy | 2025-09-11 | 2025-09-11 | 3,500 | $22.60 | $79.1K | 9,500 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | M Exercise deriv | 2025-09-08 | 2025-09-10 | 5,000 | — | $0 | 110,407 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | S Sale | 2025-09-08 | 2025-09-10 | 5,000 | $38.33 | $191.7K | 171,928 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | M Exercise | 2025-09-08 | 2025-09-10 | 5,000 | $1.80 | $9.0K | 176,928 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-08-15 | 2025-08-18 | 200 | $15.79 | $3.2K | 426,642 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-08-15 | 2025-08-18 | 8,300 | $14.98 | $124.3K | 426,842 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-07-15 | 2025-07-16 | 8,500 | $14.00 | $119.0K | 435,142 | SEC↗ |
| Silva Paul M | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 10,925 | — | $0 | 10,925 | SEC↗ |
| PAUL STEVEN M | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| Huber Reid M | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| PEREZ ROBERT J | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 10,925 | — | $0 | 10,925 | SEC↗ |
| HEALY JAMES | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| MARAGANORE JOHN | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| Young Wendy B. | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 10,925 | — | $0 | 10,925 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 10,925 | — | $0 | 10,925 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-06-16 | 2025-06-18 | 8,500 | $11.00 | $93.5K | 443,642 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-05-15 | 2025-05-19 | 8,500 | $9.56 | $81.3K | 452,142 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-04-15 | 2025-04-16 | 8,500 | $9.57 | $81.3K | 460,642 | SEC↗ |
| Sevigny Jeffrey | Chief Medical Officer | A Award deriv | 2025-04-01 | 2025-04-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Bredt David | Chief Scientific Officer | S Sale | 2025-03-14 | 2025-03-17 | 8,500 | $10.85 | $92.2K | 469,142 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | P Buy | 2025-03-13 | 2025-03-13 | 100 | $9.98 | $998 | 10,000 | SEC↗ |
| Young Wendy B. | Director | P Buy | 2025-03-12 | 2025-03-13 | 6,000 | $10.21 | $61.3K | 6,000 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | P Buy | 2025-03-12 | 2025-03-13 | 9,900 | $10.10 | $100.0K | 9,900 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | A Award | 2025-03-03 | 2025-03-05 | 13,987 | — | $0 | 171,928 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 428,000 | — | $0 | 428,000 | SEC↗ |
| Gault Cheryl | Chief Operating Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 129,000 | — | $0 | 129,000 | SEC↗ |
| Bredt David | Chief Scientific Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 142,000 | — | $0 | 142,000 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2024-11-07 | 2024-11-07 | 29,756 | — | $0 | 29,756 | SEC↗ |
| Silva Paul M | Director | A Award deriv | 2024-11-07 | 2024-11-07 | 29,756 | — | $0 | 29,756 | SEC↗ |
| PEREZ ROBERT J | Director | A Award deriv | 2024-11-07 | 2024-11-07 | 29,756 | — | $0 | 29,756 | SEC↗ |
| Young Wendy B. | Director | A Award deriv | 2024-11-07 | 2024-11-07 | 29,756 | — | $0 | 29,756 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,657 | $24.21 | $88.5K | 33,565 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,630 | $23.08 | $83.8K | 29,908 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 2,748 | $26.06 | $71.6K | 33,114 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 4,878 | $25.02 | $122.0K | 30,366 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,828 | $24.21 | $92.7K | 25,488 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,799 | $23.08 | $87.7K | 21,660 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 2,559 | $26.06 | $66.7K | 39,661 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 4,544 | $25.02 | $113.7K | 37,102 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,565 | $24.21 | $86.3K | 32,558 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 3,538 | $23.08 | $81.7K | 28,993 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 2,625 | $26.06 | $68.4K | 40,851 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-07-01 | 2024-07-03 | 4,661 | $25.02 | $116.6K | 38,226 | SEC↗ |
| HEALY JAMES | Director | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-10 | 56,091,177 | — | $0 | 0 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-10 | 8,000,000 | — | $0 | 0 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-10 | 298,103 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-10 | 20,000,000 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| HEALY JAMES | Director | C Conversion | 2024-06-10 | 2024-06-10 | 1,392,738 | — | $0 | 1,392,738 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-06-10 | 2024-06-10 | 17,861 | $17.00 | $303.6K | 17,861 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-06-10 | 2024-06-10 | 26,278 | $17.00 | $446.7K | 26,278 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-06-10 | 2024-06-10 | 25,455 | $17.00 | $432.7K | 25,455 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-06-10 | 2024-06-10 | 18,641 | $17.00 | $316.9K | 18,641 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-06-10 | 2024-06-10 | 470,589 | $17.00 | $8.00M | 1,863,327 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | C Conversion | 2024-06-10 | 2024-06-10 | 969,218 | — | $0 | 969,218 | SEC↗ |
| Third Rock Ventures V, L.P. | 10% Owner | C Conversion | 2024-06-10 | 2024-06-10 | 6,551,449 | — | $0 | 7,135,233 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion | 2024-06-10 | 2024-06-10 | 3,728,738 | — | $0 | 3,728,738 | SEC↗ |
| Ignelzi Troy A. | Chief Financial Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 81,366 | — | $0 | 81,366 | SEC↗ |
| Ceesay Abraham | Chief Executive Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 530,647 | — | $0 | 530,647 | SEC↗ |
| Yeleswaram Krishnaswamy | Chief Development Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 84,904 | — | $0 | 84,904 | SEC↗ |
| Bredt David | Chief Scientific Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 28,302 | — | $0 | 28,302 | SEC↗ |
| Gault Cheryl | Chief Operations Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 88,442 | — | $0 | 88,442 | SEC↗ |
| Galer Bradley S. | Chief Medical Officer | A Award deriv | 2024-06-06 | 2024-06-10 | 123,818 | — | $0 | 123,818 | SEC↗ |